Immunosuppressive therapy for elderly-acquired pure red cell aplasia: cyclosporine A may be more effective
- 1 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Annals of Hematology
- Vol. 99 (3), 443-449
- https://doi.org/10.1007/s00277-020-03926-6
Abstract
This current study retrospectively analyzed the clinical characteristics of 69 adult patients with acquired pure red cell aplasia (PRCA) including 40 elderly and 29 non-elderly patients from September 2009 to June 2019. The remission induction therapy regimens included cyclosporine A (CsA), corticosteroids (CS), or other immunosuppressive agents. The overall response rate was 55% (22/40) in the elderly group compared with 75.9% (22/29) in non-elderly patients (P = 0.075). In elderly patients, the best remission was achieved in the group treated with CsA than those treated with CS or other immunosuppressive agents (83.3% vs 26.7% vs 42.9%%, P = 0.004). However, outcomes of remission were similar among different treatment groups (P = 0.458) in non-elderly patients. CS induced a higher response rate in the non-elderly than that in the elderly (88.9% vs 26.7%, P = 0.009). By univariate and multivariate analysis, the clinical efficacy of elderly patients with acquired PRCA was closely associated with an induction regimen of CsA (P = 0.009; P = 0.017). In conclusion, CsA might produce higher response rate than CS and other drugs in elderly patients with acquired PRCA.Keywords
Funding Information
- State Administration of Traditional Chinese Medicine Industry Specialty (No.201407001-4)
- National Public Health Grand Research Foundation (No.201202017)
- Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institute (No. JX10231801)
- Project Funded by Jiangsu Provincial Special Program of Medical Science (No. BL2014086)
This publication has 12 references indexed in Scilit:
- Response to cyclosporine A and corticosteroids in adult patients with acquired pure red cell aplasia: serial experience at a single centerInternational Journal of Hematology, 2018
- Rational management approach to pure red cell aplasiaHaematologica, 2017
- Pure red cell aplasiaBlood, 2016
- Diagnosis and Management of Acquired Pure Red Cell AplasiaHematology/Oncology Clinics of North America, 2009
- Acquired pure red cell aplasia: updated review of treatmentBritish Journal of Haematology, 2008
- Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study groupHaematologica, 2008
- Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study GroupHaematologica, 2007
- Acquired pure red cell aplasia in JapanEuropean Journal of Haematology, 1997
- Pure red cell aplasia: Clinical features and treatment results in 16 casesAnnals of Hematology, 1996
- Treatment of refractory pure red cell aplasia with cyclosporine A: disappearance of IgG inhibitor associated with clinical responseBritish Journal of Haematology, 1991